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There are increasing number of reports on Candida albicans developing resistance to available antifungal drugs. Thus, there is an urgent need to discover new agents for treatment of candidiasis. The
alcoholic extracts of Orthoshipon aristatus have been shown to exhibit antifungal activity against
C. albicans by using the agar diffusion and broth microdilution methods. However, the underlying
mechanisms of anti-C. albicans effect of O. aristatus have not been well understood. This study
was aimed to evaluate the cytotoxic and anti-biofilm effects of the n-hexane and ethanol extracts
of purple and white varieties of O. aristatus leaves and branches against C. albicans. The effect of
n-hexane and ethanol extract against C. albicans growth was carried out by crystal violet viability
assay. IC50 values of the most active extract, and nystatin and fluconazole as positive controls were
also determined by the crystal violet assay. Evaluation of the anti-biofilm effect was performed
by treating C. albicans with the extracts at adhesion, development, and biofilm maturation stages
using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The n-hexane
extract of the purple variety of O. aristatus leaves demonstrated the strongest cytotoxic activity
against C. albicans amongst the tested extracts, with an IC50 value of 0.67 µg/mL. The extract also
showed strong anti-biofilm effect as fluconazole, with pronounced inhibition at the adhesion stage
and less activity at the biofilm development and maturation stages. These results suggested that the
n-hexane extract of the purple variety of O. aristatus leaves could be explored for discovery and
development of anti-C. albicans agent.
Keywords: Orthoshipon aristatus; anti-Candida albicans; cytotoxic; anti-biofilm

*corresponding author
Email:berna.elya@farmasi.ui.ac.id

INTRODUCTION
Candida albicans is an oval and unicellular commensal
microorganism found in the skin, vaginal and respiratory
mucosa. However, it can turn into a pathogen and cause
superficial and systemic candidiasis mainly caused by
immune suppression (Kadosh & Lopez, 2013). Candidias
can usually be suppressed by fluconazole, however in
recent years it has been reported that the incidence of
C. albicans resistance against azole and nystatin has
been increasing (Oxman et al., 2010; Mohamadi et al.,
2014; Sandai et al., 2016). The presence of biofilms and
wide use of azole drugs have been identified as one of
the resistance factor (Lortholary et al., 2010). Thus, the
emergence of C. albicans resistance is the major driving
factor for development of novel anti-Candida albicans
drugs.
Numerous reports showed that natural products such
as herbal medicine or its derivatives possess potential
antiviral, antimicrobial, or anti-fungal activity (Atanasov

et al., 2015). Manuka honey has been reported not only
to exhibit antibacterial activity but also antiviral activity
(Watanabe et al., 2014). Epigallocatechin gallate was
also demonstrated to exhibit the Zika virus growth in
vitro (Raekiansyah et al., 2018). Furthermore, Rooibos
tea showed activity against Influenza virus type A and B
(Rahmasari et al., 2017). Consequently, the anti-fungal
activities of herbal medicines, and their constituents are
of great research interest.
Orthosiphon aristatus is a plant distributed across South
East Asia and South Asia. It is also known as kumis
kucing in Indonesia, misai kucing in Malaysia, and
java tea in United States. It is traditionally used for the
treatment of kidney stone bladder, vaginitis, urinary
infection, and rheumatoid (Mukesh et al., 2015). There
are two varieties of O. aristatus grown in Indonesia,
namely, white and purple flower. To note, the purple
variety is known to contain more bioactive compounds
compared to the white variety (Ashraf et al., 2015). In
general, O. aristatus has been reported to contain the
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glycoside orthoshipon, terpenoids, and flavonoids such
as eupatorin, sinensetin, salvigenin, ladanein, vomifoliol,
5-hydroxy-6,7,3´,4´- tetramethoxyflavone, 6-hydroxy5,7,4´-trimethoxyflavone, 7,3´,4´-tri-O-methylluteolin,
tetramethylscutellarein and scutellarein tetramethylether
(Lyckender & Malterud, 1996; Tezuka et al., 2000).
A previous study used the agar diffusion method to
demonstrate the anti-C. albicans activity of ethanol
extract of O. aristatus (Romula et al., 2018). However,
the effect of direct contact between various extracts of
O. aristatus and C. albicans cells as well as the analysis
of the possible mode of action, have not been reported.
In the present study, we investigated the anti-C. albicans
activity of n-hexane and ethanol extracts of both white
and purple varieties of O. aristatus by evaluating their
cytotoxic and anti-biofilms effects. We found that the
n-hexane extract of leaves of the purple O. aristatus
potently suppressed the viability of C. albicans and
interfered with the adhesion stage in biofilm formation.
MATERIALS AND METHODS
Cells and Samples
Candida albicans ATCC 10231 were grown in a 90 mmpetri dish containing potato dextrose agar (Wako Pure
Chemical Industries, Osaka, Japan) and maintained in
an incubator at 28ºC. For experimental purposes, C.
albicans from the petri dish were further transferred
into slant potato dextrose agar and incubated at 28ºC
for 24 h. Nystatin (Metiska Farma, Jakarta, Indonesia)
and fluconazole (Novell Pharmaceutical Laboratories,
Jakarta, Indonesia) were dissolved in ultrapure water.
Dried of 3 months old O. aristatus white and purple
varieties were purchased from Balai Penelitian Obat dan
Rempah Indonesia on August, 2019 (Bogor, Indonesia)
and identified in Lembaga Ilmu Pengetahuan Indonesia
(Indonesian Institute of Science, Bogor Indonesia).
Extract Preparation
One gram each of dried branches and leaves of white and
purple varieties of O. aristatus was extracted with 100
mL of n-hexane (Wako Pure Chemical Industries, Osaka,
Japan) and shaken at 37°C for 3 h. After Whatman paper
filtration, the filtrate was vacuum evaporated to obtain
the n-hexane extract and the residue was further extracted
by 96% ethanol (Wako Pure Chemical Industries, Osaka,
Japan) and shaken at 37°C for 3 h. After centrifugation
at 3000 rpm for 15 min (Tomy Mx-305), the extract was
filtrated by Whatman paper and vacuum evaporated
to obtain the ethanol extract. The dried extracts were
dissolved in DMSO (0.2g/mL) and the final DMSO
concentration in each reaction mixture was 1%.
Crystal Violet Viability Assay
The crystal violet viability assay was carried out using a
96 well-culture plate coated with 50% fetal bovine serum
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(Sigma Aldrich, St. Louis, America). A volume of 100
µL/well of tested extract diluted in sabouraud dextrose
broth (SDB) (Wako Pure Chemical Industries, Osaka,
Japan) was added into 96 well-culture plates followed
by the addition of 100 µL/well of C. albicans (3×104
cells/well) in SDB. The mixture was then incubated at
28°C for 48 h. The supernatant was then aspirated, and
the cells were fixed with 70% ethanol and stained with
0.5% crystal violet. Cells were dried and diluted by 96%
ethanol. The absorbance was measured at 460 nm using
a microplate reader (VersaMax Molecular Devices,
California, USA).
The selected extract of O. aristatus which shown
highest activity in inhibiting C. albicans were subjected
to a serial dilution to obtain solutions of 2, 1, 0.5, 0.25,
0.125, 0.062, 0.031 and 0.016 mg/mL. The percentage
inhibition was calculated using Microsoft Excel
software, and the 50% inhibition concentration (IC50)
was determined by linear regression analysis.
Biofilm Susceptibility Assay
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) assay was carried out to evaluate the efficacy
of O. aristatus extracts in interrupting biofilm formation
using 96 well-flat bottom polystyrene titre plates
according to Traba and Liang (2011). Evaluation of the
inhibitory effects was performed by treating C. albicans
at adhesion, development, and biofilm maturation stages
using a modified time of addition assay by Raut et al.
(2013). In brief, 100 µL/well of C. albicans (3×106
cells/well) in SDB was dispensed aseptically into 96
well-culture plates coated with 50% fetal bovine serum
(Sigma Aldrich). For the adhesion stage study, the plate
was incubated at 37ºC for 2 h with and without extract.
Supernatant then was aspirated, followed by the addition
of 100 µL/well of fresh SDB and 50 µl/well MTT in
0.15 M PBS (1:5). After 3 h of incubation under dark
condition at room temperature, 50 µL/well of DMSO
was added. The absorbance was then measured at 570
nm (Versa Max). For the bioﬁlm development stage,
after 2 h of incubation at 37ºC, the supernatant was
aspirated and washed by PBS to remove non adhered
cells followed by the addition of fresh SDB (100 µl/
well) with and without extract and incubation at 37◦C for
24 h. The cell viability was measured by MTT reagent
(Sigma Aldrich, St. Louis, America). MTT assay was
carried out by monitoring the reduction of MTT after
3 h of incubation under dark conditions. The reduction
product was solubilized in DMSO (50 µl /well), and OD
was read at 570 nm. The biofilm maturation stage study
was carried out by using 24 h old bioﬁlm. Wells with 24
h old bioﬁlm were washed with PBS followed by the
addition of 100 µl/well SDB (with or without extract).
Cells were further incubated at 37ºC for 48 h, and cell
viability was then measured by MTT as described above.
E-ISSN 2477-0612
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Statistical Analysis
The data were presented as means ± standard error
(SE) from three independent experiments. Each test
condition was carried out in triplicate. The IC50 values
of the samples were obtained from at least three
determinations. In order to avoid the artefact activity,
negative control (medium containing solvent or medium
containing extract without C. albicans) were also tested.
RESULTS
Figure 1 shows that the n-hexane and ethanol extracts
of white (W) and purple (P) varieties of O. aristatus
leaves (WL, PL) and branches (WB, PB) could inhibit
C. albicans viability as indicated by lower % relative
C. albicans cell density as compared to the negative
control. Treatment with 3.125 UI/mL nystatin (equal to
0.62 µg/ml) as a positive control, resulted in the lowest
C. albicans cell viability. The ethanol extracts of both
white and purple varieties (WL, WB, PL, PB) exhibited
strong cytotoxicity with 50% relative cell density
while the n-hexane extracts of WL, WB and PB of O.
aristatus showed relatively higher % cell viability.
Among the extracts tested, the n-hexane extract of PL
variety showed the lowest % relative C. albicans cell
density. The n-hexane extract of O. aristatus PL was
also observed as the only extract which caused less than
50% of relative C. albicans cell density as compared to
the negative control. The IC50 value of the n-hexane
extract of O. aristatus PL was 1.3±0.15 mg/mL mg/mL
which was higher than that of nystatin (0.07 ± 0.002 µg/
mL) and fluconazole (3.36 ± 0.7 µg/mL) as shown in
Table 1 respectively.
Table 1. IC50 value
Sample

IC50 Value (µg/mL)

n-hexane extract PL

1300 ± 150

Nystatin

0.07 ± 0.002

Fluconazole

3.36 ± 0.7

PL, leaves of purple variant

In the biofilm inhibition assay, fluconazole, a widely
used anti-fungal drug was used as the positive control
(Maubon et al, 2014). The addition of n-hexane extract
of O. aristatus PL and fluconazole at the adhesion
stage showed a significant decrease of C. albicans cells
compared to untreated cells (Figure 2). The n-hexane
extract of O. aristatus PL reduced C. albicans viability
by more than 10% than that of fluconazole at the
adhesion stage. The n-hexane extract of O. aristatus
PL caused 69.2% decrease of C. albicans cells, higher
than that of fluconazole (54.7%). At the development
E-ISSN 2477-0612
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stage, mild inhibition activity of C. albicans growth
was observed for both n-hexane extract of O. aristatus
PL (57.1%) and fluconazole (57.3%). However, both
n-hexane extract and fluconazole caused less inhibition
to a mature biofilm.
DISCUSSION
The anti-C. albicans activity of O. aristatus purple and
white varieties extracts were evaluated using the crystal
violet (CV) viability assay. CV stained the adherent
live C. albicans cells. Meanwhile, the dead cells of C.
albicans, following sample treatment, were detached
from the culture dish. Low activity of sample against
C. albicans cells prevented cells from detachment,
leading to high levels of CV staining similar to untreated
cells (negative control). In this assay nystatin was
used as a positive control because of its susceptibility
against C. albicans (Khan et al., 2018). Screening and
IC50 evaluation of the ethanol dan n-hexane extracts of
purple dan white variants of O. aristatus branches and
leaves indicated that the n-hexane extract of O. aristatus
PL showed the strongest cytotoxic effect on C. abicans
This result suggested that the extract could be a potential
source for discovery of lead compound for development
of antifungal agent against C. albicans infection.
One of the virulence factors of C. albicans is the ability
to form a biofilm (Lohte et al., 2018). Thus, the effect
of n-hexane extract of O. aristatus PL against biofilm
formation was evaluated at adhesion, development, and
maturation stage of biofilm formation. In the biofilm
formation assay, fluconazole was used as the positive
control to inhibit the adhesion process of C. albicans.
The n-hexane extract of O. aristatus PL showed a
similar inhibitory result as fluconazole with pronounced
inhibition at the adhesion stage and less activity at the
biofilm development and maturation stages, respectively.
Fluconazole was reported not only disrupted the
membrane and wall integrity but also decreased the
incorporation of hyphal-associated wall proteins (As3,
hwp1, and P1b5) and wall repaired related protein,
which interferes the C. albicans adhesion process (Sorgo
et al., 2011). In the adhesion process, cell wall proteins
such as hwp1 play indirect roles in the adhesion process
(McCall et al., 2011).
Neharkar & Laware (2013) reported the antifungal
activity of hydro-alcoholic extract of O. stamineus
against C. albicans by using the disk and agar diffusion
method. The anti-C. albicans activity of the plant was
further confirmed by Romulo et al. (2018) who screened
the antifungal activity of the ethanol extracts of many
Indonesian plants including O. aristatus using the broth
microdilution method. However, they didn’t mention the
varieties of tested Orthosiphon aristatus. Among the
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Figure 1. The cytotoxic effect of O. aristatus extracts (100 µL/well) against
C. albicans. Data are represented as the mean ± standard error - from two
independent experiments (each in triplicate). Nystatin was tested at 500 UI/
mL. Control, untreated cells; WB, branch of white variant; WL, leaves of white
variant; PB, branch of purple variant; PL, leaves of purple variant.

Figure 2. Inhibition of biofilm development of C. albicans by the n-hexane
extract of leaves of O. aristatus purple variant (PL) (2 mg/mL) and fluconazole
(6 µg/mL). Data are represented as the mean ± standard error of mean from
two independent experiments (each in triplicate).
plants investigated, the extract of O. aristatus exhibited
the strongest antimicrobial effect, inhibiting the growth
of C. albicans at MIC value of 128 μg/mL. The active
components of O. aristatus extract in these studies
were polar and possibly phenolic. The anti-fungal
action of phenolic compounds have been suggested
to be through cell membrane disruption, inhibition of
cell wall formation, and inhibition of the mitochondria
(Freiesleben & Jager, 2014; Shahzad et al., 2014).
In this study, we demonstrated for the first time that
the n-hexane and ethanol extracts of white and purple
varieties of O. aristatus, exhibited inhibitory activity
against C. albicans due to their cytotoxic and anti-biofilm
effects. The results revealed that the n-hexane extract of
O. aristatus PL possessed the strongest activity against

C. albicans compared to the other tested extracts. The
extract mainly inhibited the adhesion stage of biofilm
formation.
The active constituents of the n-hexane extract of O.
aristatus PL, which were responsible for inhibiting
C. albicans, have not been identified. The n-hexane
extract contained non polar constituents of O. aristatus
including the essential oils. Hossain et al. (2008)
identified the chemical composition and anti-fungal
effects of the essential oil of O. stamineus against various
phytopathogenic fungi. The oil was mainly consisted
of terpenoids with β-caryophyllene, α-humulene,
β-elemene, β-bourbonene and caryophyllene oxide as
the major sesquiterpenes while 1-octen-3-ol, β-pinene,
E-ISSN 2477-0612

136

Pharm Sci Res, Vol 7 No 3, 2020

Rahmasari, et al.

camphene and limonene were the major monoterpenes.
Terpenoids have been reported to be able to disrupt the
cell membrane, and some of them were also able to
destroy the fungal mitochondria (Freiesleben & Jager,
2014). In addition, it was reported that terpenoids
potentially inhibited C. albicans cells growth at the
hyphal form, which is also important for adhesion
maintaining process of biofilm formation (McCall et
al., 2019; Zore et al, 2011). Thus, it is proposed that
active compound(s) of n-hexane extract of O. aristatus
PL might block the adhesion process by disrupting the
hyphal form. However, further evaluation is needed to
understand the underlying mechanism.

antenatal clinic in tertiary care hospitals of Peshawar.
Infection and Drug Resistance, 11:447-456.

CONCLUSION

Lyckender, I.M., Malterud, K.E. (1996). Lipophillic
flavonoids from Orthosiphon spicatus prevent oxidative
inactivation of 15-lipoxygenase. Prostaglandins,
Leukotrienes & Essential Fatty Acids, 54:239-246.

Our present results suggest that the n-hexane extract
of leaves of a purple variant of O. aristatus has potent
inhibitory effects against C. albicans. Further studies
are necessary to identify the bioactive constituents
contributing to the antifungal activity and an indepth
study to understand the underlying mechanisms of
anti-C. albicans effect. The toxicity of the plant extract
against human cell line should also be carried out to
determine its safety for human use.
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